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Generation of a Homozygous 
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Calcium Signaling
Kornélia Szebényi1,*, András Füredi1,*, Orsolya Kolacsek1,*, Enikő Pergel1, Zsuzsanna Bősze2, 
Balázs Bender3, Péter Vajdovich4, József Tóvári5, László Homolya1, Gergely Szakács1, 
László Héja6, Ágnes Enyedi7, Balázs Sarkadi1,8, Ágota Apáti1 & Tamás I. Orbán1
In drug discovery, prediction of selectivity and toxicity require the evaluation of cellular calcium 
homeostasis. The rat is a preferred laboratory animal for pharmacology and toxicology studies, 
while currently no calcium indicator protein expressing rat model is available. We established a 
transgenic rat strain stably expressing the GCaMP2 fluorescent calcium sensor by a transposon-based 
methodology. Zygotes were co-injected with mRNA of transposase and a CAG-GCaMP2 expressing 
construct, and animals with one transgene copy were pre-selected by measuring fluorescence in 
blood cells. A homozygous rat strain was generated with high sensor protein expression in the 
heart, kidney, liver, and blood cells. No pathological alterations were found in these animals, 
and fluorescence measurements in cardiac tissue slices and primary cultures demonstrated the 
applicability of this system for studying calcium signaling. We show here that the GCaMP2 expressing 
rat cardiomyocytes allow the prediction of cardiotoxic drug side-effects, and provide evidence for the 
role of Na+/Ca2+ exchanger and its beneficial pharmacological modulation in cardiac reperfusion. Our 
data indicate that drug-induced alterations and pathological processes can be followed by using this 
rat model, suggesting that transgenic rats expressing a calcium-sensitive protein provide a valuable 
system for pharmacological and toxicological studies.
The importance of proper calcium homeostasis and signaling from the cellular to the complex organ 
levels is well appreciated: both in physiological and pathological processes cellular free calcium plays a 
major role1. Disruption of the calcium homeostasis by pharmacological agents or pathological conditions 
correlate with various conditions, including prolonged QT intervals and arrhythmias in the heart2,3, or 
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ischemic kidney injuries resulting in poor outcome for kidney transplantations4. In fact, several drugs 
with various mechanisms of action had to be withdrawn from the market because of side effects caused 
by disruption of the calcium homeostasis, including Clobutinol, a cough suppressant5, Dofetilide, an 
antiarrhythmic agent6, Grepafloxacin and Sparfloxacin, antibacterial agents7, Terfenadine, an antihista-
mine8, or Terodiline, a spasmolytic agent9. All these findings suggest that in the process of drug discovery 
an early prediction of toxicity requires the direct examination of the drug effects on cellular calcium 
homeostasis and signaling in different target tissues, especially in the heart.
Animals stably expressing high-sensitivity cellular calcium indicator proteins are best suitable for 
direct examination of calcium signaling events in cells, tissues and organs as well. A well-established 
genetically engineered calcium sensor protein is the GCaMP2, containing a calmodulin-based sensor and 
a GFP-based fluorescent protein, which can be directly used to determine the changes in cellular calcium 
concentration10. The GCaMP2 protein has already been applied in tissue preparations and in transgenic 
mice11–14, as well as in human pluripotent stem cells15, allowing calcium imaging without additional 
manipulation. However, a calcium sensor expressing rat model has not been available yet.
Several methods are available for the transgenesis of rats, however, transposase-catalyzed gene delivery 
provides advantages, such as increased efficiency of chromosomal integration and single-copy insertion, 
while the system is less prone to genetic mosaicism and gene silencing than lentiviral gene delivery16. 
It has also been documented that the SB100X-mediated transgene integration allows the generation of 
transgenic lines with tissue-specific expression patterns, specified by selected promoter elements17.
In the present work we have generated transgenic laboratory rats expressing the fluorescent cal-
cium sensor protein GCaMP2. In order to achieve high-level expression in cardiac tissues, GCaMP2 
expression in our model system is driven by a CAG promoter variant proved to be highly active in 
human embryonic stem cell-derived cardiomyocytes18. Additionally to cardiac tissues, characterization of 
homozygous CAG-GCaMP2 rats demonstrated appreciable GCaMP2 expression in kidney cortex, liver, 
and blood cells. CAG promoter specific GCaMP2 expression in blood cells allowed the development of 
a non-invasive, combined approach of genetic and phenotypic selection, yielding rat strains with high 
sensor protein expression, in spite of a mono-allelic transgene incorporation.
To validate the applicability of this model system in physiological and pharmacological studies, we 
used ex vivo and in vitro cardiomyocyte preparations to examine the effects of various ligands and poten-
tial drugs, such as the antimalarial agent, mefloquine, reported to disrupt the calcium homeostasis of 
heart tissue19; terodiline, causing prolongation of the QT interval and cardiac arrhythmia20; and terfen-
adine, known to prolong the QT interval through inhibition of the delayed rectifier potassium current 
of isolated rat ventricular myocytes21. Moreover, we examined the function of the Na+/Ca2+ exchanger 
(NCX) by using an in vitro cellular hypoxia-reperfusion model, and found a rapid rise in cellular calcium 
during reoxygenation, blocked by an NCX inhibitor, KB-R7943. This finding further supports a major 
role of NCX, working in a reverse mode, in the calcium overload during reperfusion following ischemia22, 
and that the inhibition of NCX may decrease calcium overload in ischemia/reperfusion (see23).
Results
Generation of a transgenic rat strain by combined genetic and phenotypic selection. To 
establish a rat strain with a single transgene copy per haploid genome, a combined genotype and pheno-
type screening procedure was applied. First, microinjected zygotes were implanted into pseudopregnant 
females to be carried to parturition. In order to promote integration and avoid concatemerization of the 
transgene, the transposon vector was applied as a circular plasmid, together with the SB100X transposase 
mRNA; the latter one was necessary to minimize mosaicism by providing a translatable source of the 
transposase during early cell divisions when the host genome is transcriptionally inactive.
Next, newborn rats were screened for transgene integration based on their tail tissue-derived gDNA, 
using SB transposon specific PCR primers. Transposase-induced insertion yielded a high percentage, 
about 21% of transgenic animals (16 carriers among 75 newborns). To avoid high transgene copy num-
ber related phenotypic alterations, low copy number carriers were selected at the F0 generation through 
determining average transgene copy numbers by a methodology developed earlier24. SB copy number 
distributions were more skewed than expected by earlier studies on cell lines25,26: apart from 3 extreme 
cases, the majority of the carriers had copy numbers below 2 (Fig. 1A). The relatively high number of 
genetically mosaic offspring (copy number < 1) was also notable, although two chosen ones showed 
stable germ line transmission (Table 1).
Founders (F0) with one copy number were crossed with wild type rats to generate low copy number 
animals with stable transgene integration (F1 generation) (Table 1). Due to its constitutive feature, the 
CAG promoter driven expression of GCaMP2 was expected to be detectable in leukocytes. In order to 
accelerate the selection for the desired phenotype, F1 rats with single-copy integration were screened 
for functional GCaMP2 expression in leukocytes via FACS measurements (Fig.  1B). Single transgene 
carrier F1 rats with high sensor protein expression were further crossed with wild type counterparts 
to ensure stable genetic inheritance (F2 generation). GCaMP2 expression levels detected in leukocytes 
by FACS measurements were later also confirmed to be similar in primary cardiac cells isolated from 
the same animals (Supplemental Figure 1). Single-copy F2 rats were then inbred to generate homozy-
gous offspring (F3 generation), carrying 2 copy transgenes, one per each haploid genome. Since the F3 
generation contains not only homozygous, but also heterozygous and transgene negative animals, our 
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Figure 1. Genotype and phenotype analyses during the establishment of a CAG-GCaMP2 expressing 
transgenic rat strain. (A) Determining the average transgene copy numbers in rat tail tissue samples of the 
founder (F0) generation using a previously developed, real-time PCR based methodology, applying TaqMan® 
assays specific for the left and the right inverted repeat-direct repeat transposon sequences (RQ-IRDR-
L/R, see Methods). Mean values ± confidence intervals are shown; ref1/2/3 stand for previously genotyped 
reference clones with one transposon copy, rgDNA is a non-transgenic rat tissue sample (as a negative 
control). (B) Flow cytometry analysis of leukocytes obtained from the blood of transgene positive F1 rats 
with single-copy integration. A transgene negative F1 rat was used as control. DRAQ5 was used to identify 
cells with nuclei (leukocytes). 10 μ M Ionomycin was used to confirm GCaMP2 expression by testing its 
functionality. Gated % and median values are indicated by red numbers on the histograms. (C) The genomic 
integration locus of the transgene in the homozygous rat strain as determined by splinkerette PCR.
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approach provided a special advantage at this point: homozygous rats could be selected by copy number 
determination, instead of crossing transgenic F3 rats with wild type rats for identification of homozygous 
ancestor.
Variance in the expression profile of the GCaMP2 protein through subsequent generations and among 
litter mates was monitored via FACS measurements of ionomycin induced changes in intracellular cal-
cium levels of primary cells isolated from the left ventricular wall (Supplemental Figure 2). The estab-
lished and constantly maintained homozygous rat strain (‘Line I.’ in Table 1) was proven to be genetically 
stable: transgene copy numbers and expression profiles were not altered through four subsequent gener-
ations. In addition, cell karyotypes were also stable and showed no difference in terms of chromosome 
numbers and integrity. Transgene integration locus was determined by a splinkerette-PCR method as 
described earlier18: the integration per se is not expected to influence gene expression profiles from the 
neighboring genetic loci (Fig. 1C).
Expression of the calcium sensor protein in homozygous transgenic rats. We examined if the 
expression of the calcium sensor caused any phenotypic alterations in transgenic (TG) rats. Brain, lung, 
spleen, kidney, liver and heart sizes were in all cases similar in the wild-type and homozygous TG rats 
(data not shown). Comparison of heart and body weights did not show any significant differences (heart 
weight/body weight ratios are (in mg/g): 4.808 ± 0.087 for WT and 4.854 ± 0.356 for TG, n = 8 animals, 
see Table 2), only a 15% increase was observed in the apical left ventricle (LV) thickness (close to apex, 
2.66 mm ± 0.42 for WT and 3.1 mm ± 0.38 for TG, see Table 3), implying a possible LV apical hypertro-
phy. This result was confirmed by examination of hematoxylin and eosin stained tissue slices prepared 
from the left ventricle, where only a mild cardiomyocyte hypertrophy was found (Supplemental Figure 3). 
However, further studies showed no significant pathological alterations in O2 saturation (97% ± 0.71 for 
WT and 95.3% ± 0.47 for TG,), fractional shortening (23.09% ± 6.59 for WT and 29.74 ± 6.54 for TG, 
obtained by cardiac ultrasound measurements, see Methods) and LV wall thickness at base (close to 
Wild type crossings of founders
(Line II.) (Line I.) (Line III.) (Line IV.)
Parents ♂ ♀ ♂ ♀ ♂ ♀ ♂ ♀ 
F0/20 WT F0/26 WT F0/34 WT F0/49 WT
Average copy 1.0 – 1.0 – 0.4 – 0.9 –
F1 Progeny Copy Progeny Copy Progeny Copy Progeny Copy
F1/36 0 F1/68 1 F1/51 0 F1/17 1
F1/37 1 F1/69 0 F1/52 0 F1/18 0
F1/38 1 F1/70 1 F1/53 1 F1/19 0
F1/39 0 F1/71 1 F1/54 0 F1/20 0
F1/40 0 F1/72 0 F1/55 1 F1/21 1
F1/41 0 F1/73 0 F1/56 0 F1/22 0
F1/42 0 F1/74 1 F1/57 0 F1/23 0
F1/43 2 F1/75 1 F1/58 1 F1/24 1
F1/44 1 F1/76 0 F1/59 0 F1/25 1
F1/45 0 F1/77 1 F1/60 0 F1/26 1
F1/46 0 F1/78 1 F1/61 1 F1/27 0
F1/47 0 F1/79 0 F1/62 0 F1/28 1
F1/48 0 F1/80 0 F1/63 1 F1/29 0
F1/49 0 F1/81 1 F1/64 0 F1/30 0
F1/50 1 F1/82 0 F1/65 0 F1/31 0
F1/83 1 F1/66 0 F1/32 1
F1/84 0 F1/67 1 F1/33 1
F1/85 0 F1/34 0
F1/35 1
Table 1.  Genotype analyses of the F1 generation offspring of four chosen F0 individuals crossed with 
wild type rats. Based on further genetic and phenotypic characterizations, ‘Line I.’ rat line was used to 
establish the homozygous rat strain with one copy CAG-GCaMP2 transgene per haploid genome. Of note 
that although the F0/34 founder of ‘Line III.’ was a genetic mosaic (average copy number below 1), it stably 
inherited one transgene copy in its germline (see F1 animals).
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aorta, 3.38 mm ± 0.6 for WT and 3.57 mm ± 0.33 for TG) in GCaMP2-expressing rats, as compared to 
wild-type control (Table 3).
Fluorescence images of brain, lung, spleen, kidney, liver, atria and ventricles of TG and WT rats 
were compared using an in vivo imaging system to confirm GCaMP2 expression. Kidney, liver and 
heart, especially the atria were found to have high GCaMP2 fluorescence intensities (Fig.  2A), while 
GCaMP2 expression in the lung, brain and spleen failed to reach detectable levels (data are shown only 
for lung). The observed differences among the different tissues could have been caused either by different 
intracellular calcium levels or different GCaMP2 expression levels. Therefore, we examined GCaMP2 
protein expression in samples obtained from different organs of TG rats by immunohistochemistry, and 
confirmed higher protein levels of GCaMP2 in the kidney, liver and heart samples while in brain, lung 
and spleen measurable GCaMP2 expression could not be detected (Fig. 2B,C). Functional expression of 
GCaMP2 could be confirmed in isolated primary cardiac (Supplemental Figure 2), renal27 and hepatic 
cells (unpublished observations by L. Homolya). Consistent with higher protein levels of GCaMP2, higher 
mRNA expression could be confirmed in the kidney, liver and heart samples, while brain, lung and 
spleen were found to express low levels of the transgene mRNA (Supplemental Figure 4A). Low variance 
in mRNA expression levels among homozygous GCaMP2 rats was confirmed when two rats from the 
same litter were analyzed (Supplemental Figure 4A). This finding was in good agreement with the low 
variance of GCaMP2 expression measured by FACS in cardiac primary cells isolated from littermates 
(Supplemental Figure 2). Differences in protein expression intensities in the kidney between cortex and 
medulla or in the heart between atrium and ventricles detected by the fluorescent in vivo imaging system 
were also present at the transcriptional level (Supplemental Figure 4B and C).
Direct examination of calcium signaling in cardiomyocytes by using CAG-GCaMP2 transgenic 
rats. Acute ventricular slices were characterized for ionomycin-induced Ca2+ signals to confirm the 
functional expression of the GCaMP2 protein (Fig. 3A). In the TG tissue slices, intracellular Ca2+ over-
load could be evoked by 10 μ M ionomycin, initiating a wave of calcium rise running through the slices, 
while intracellular calcium could be depleted by 10 mM EGTA (Supplemental movie 1). Ionomycin and 
EGTA administration also induced small changes in autofluorescence in the WT animal heart slices, 
however, these changes were two orders of magnitude smaller than the GCaMP2-dependent signals in 
the TG slices.
Freshly prepared ventricular slices often showed spontaneous contractions, resulting in fluorescence 
intensity changes in TG slices (Fig. 3B). Spontaneous contractions were localized within the tissue slices 
and did not generate major artifacts, as confirmed by the absence of changes in the autofluorescence sig-
nal in spontaneously contracting WT ventricular slices (Fig. 3B). Thus acute tissue slices can be properly 
used to follow the calcium transients and contractions in the TG heart tissue samples.
The TG CAG-GCaMP2 rat provides a stable and constant source of primary cardiac cells, suitable for 
a detailed examination of calcium signals in imaging-based drug screening applications. Therefore we 
examined the functionality of the GCaMP2 calcium indicator protein in primary cells isolated from the 
atria or from the ventricles. Cardiomyocyte-identity of the isolated cells was confirmed by immunostain-
ing against the cardiac Troponin T and the cardiac isoform of the NCX protein (Supplemental Figure 5).
Weight (g, SD)
O2 saturation 
(%, SD)
Fractional 
shortening (%, 
SD)
LV Thickness 
at base (mm, 
SD)
LV Thickness 
at apex (mm, 
SD)
WT 
(n = 4) 203.75 ± 14.74 97 ± 0.71 23.09 ± 6.59 3.38 ± 0.6 2.66 ± 0.42
TG 
(n = 3) 240.67 ± 22.9 95.33 ± 0.47 29.74 ± 6.54 3.57 ± 0.33 3.1 ± 0.38
Table 3.  Comparison of body and heart parameters of wild type (WT) and CAG-GCaMP2 (TG) rats.
n
WT TG
8 8
body weight (g) 198 ± 29.399 213.375 ± 48.382
heart weight (mg) 953.625 ± 152.669 1032.750 ± 226.265
heart weight/body 
weight ratio (mg/g) 4.808 ± 0.087 4.854 ± 0.356
Table 2.  Body and heart weight of wild type (WT) and transgenic (TG) rats. The data represents mean 
values ± S.E.M (n=8).
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Figure 2. Expression of the GCaMP2 calcium sensor in transgenic rats. (A) Fluorescence (upper) and 
bright field (lower) images of wild type (WT) and transgenic (TG) kidney, liver, heart atria, ventricles and 
lung. (B) Immunohistochemistry of transgenic brain, spleen, lung, renal cortex, liver, and heart ventricle 
at lower magnification (scale bars represent 100 μ m). (C) Immunohistochemistry of transgenic liver, renal 
cortex, heart ventricle and atrium at higher magnification (scale bars represent 50 μ m). Immunostaining of 
the GCaMP2 was performed by a GFP-recognizing antibody. Hoechst (Hst) was used to stain the nuclei.
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Figure 3. CAG-GCaMP2 expressing ventricular slices and cardiac cultures allow detection of 
spontaneous and ligand-induced calcium signals. (A) The left panel shows the fluorescence image of 
a ventricular slice obtained from a transgenic rat heart with circled region of interest (ROI). The right 
panel shows the effect of ionomycin and EGTA administration on the kinetics of calcium signals in the 
indicated ROIs. (B) The left panel shows the fluorescence images of transgenic (TG) and wild type (WT) 
ventricular slices with circled region of interest (ROI). The right panel shows the fluorescence signals caused 
by spontaneous calcium waves in TG and WT ventricular slices in the indicated ROIs. (C) Spontaneous 
calcium oscillations were induced by adrenalin and ATP in ventricular cell cultures generated from 
GCaMP2 expressing rats. Cell cultures obtained from the heart of TG rats were treated with adrenalin, ATP, 
ionomycin and EGTA. Physiologically relevant ligands such as adrenalin or ATP evoked a strong increase in 
intracellular Ca2+ levels and both compounds induced spontaneous calcium oscillations after addition.
www.nature.com/scientificreports/
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In order to document the applicability and limitations of this system, isolated and cultured rat ven-
tricular cardiomyocytes were characterized for spontaneous and ligand-induced Ca2+ signals by confo-
cal microscopy. At high magnification, administration of 10 μ g/ml adrenalin caused a well measurable 
oscillation, while 100 μ M ATP further increased the frequency of oscillations in ventricular cells without 
reaching the limit of detection (Fig. 3C). Detection of calcium signals at lower magnification provided a 
more high throughput application by calculating the average of Ca2+ transients evoked by adrenalin and 
ATP in atrial and ventricular cultures, while oscillations of single cells was still detectable as shown by 
the high S.E.M. values (Fig. 4A). For validation of calcium signals evoked by adrenalin and ATP, sim-
ilar measurements were carried out with Fluo4-AM loaded cardiomyocytes isolated from WT animals 
(Fig. 4B), resulting in similar calcium signals.
To document the applicability of this system for drug testing, we have examined the effect of 6 μ M 
terfenadine and 10 μ M terodiline on the basal calcium levels in ventricular myocytes. We used terfena-
dine instead of its active metabolite fexofenadine (terfenadine carboxylate), a potent antihistamine agent 
because it was reported that terfenadine itself is the likely cause of the cardiotoxic effect8,28. Treatment 
with 10 μ M terodiline caused elevation in basal calcium levels, moreover, terodiline pre-treatment 
resulted in a significant increase in the amplitude of adrenalin-induced calcium transients (Fig. 4C). The 
ATP-evoked calcium influx was also elevated when ventricular cultures were pre-treated with terodil-
ine or terfenadine, while terfenadine had only moderate effect on the adrenalin-induced calcium influx 
(Supplemental Figure 6).
We used the GCaMP2 rat system to examine the effect of an antimalarial, and potentially cardiotoxic 
agent, mefloquine, on the calcium signal responses in the primary cardiomyocyte cultures. As shown 
(Fig.  4D), higher mefloquine concentrations induced an increase in cellular calcium levels both in the 
atrial and ventricular CMs, but mefloquine had different effects on the ligand-induced signals. Atrial 
CMs showed a decrease in ligand-induced Ca2+ influx, however, the upstroke kinetics of the calcium 
transients were not significantly altered (Supplemental Figure 7A and B). Ligand-induced calcium signals 
in ventricular CMs were affected in their upstroke kinetics by mefloquine, as shown in Supplemental 
Figure 7A and B, that is mefloquine-treated ventricular CMs showed higher ‘time to peak’ values as 
compared to control ventricular CMs. It also appeared that adrenalin induced calcium signals were more 
affected by mefloquine than the ATP-induced signals.
We found that a 24 hours pre-treatment with near therapeutic (2.6 μ M) concentrations of mefloquine 
did not increase the basal calcium levels in cardiomyocytes, however, calcium signals induced by adren-
alin or ATP were similarly altered as after the immediate addition of 37.5 μ M mefloquine (Supplemental 
Figure 7A).
After the occurrence of a cardiac hypoxia, (e.g.: by acute myocardial infarction), reperfusion causes 
major cell death in patients mostly through an altered calcium handling29. To mimic ischemia (hypoxia) 
and reperfusion (reoxygenation) at an in vitro cellular level, we pre-treated rat primary ventricular cells 
with 400 μ M CoCl2, and after 24 hours we rapidly exchanged the medium for an oxygenated one, con-
taining no CoCl2. Reoxygenation caused a significant calcium increase, while the medium change with-
out CoCl2 pre-treatment did not alter the intracellular calcium levels (Fig. 5A,B).
At the time of reperfusion/reoxygenation, following the ATP depletion and intracellular Na+ increase 
produced by hypoxia, the reverse-mode activation of the NCX has been suggested to be a key factor in 
cellular calcium loading22. Thus the inhibition of NCX and the related calcium influx during initial rep-
erfusion may reduce myocardial injury23. In order to explore this effect, different concentrations of the 
NCX inhibitor, KB-R7943, were added to the primary ventricular cells at the time of reoxygenation. This 
treatment, in a concentration dependent manner, decreased or eliminated the rise in cellular calcium due 
to reoxygenation (Fig. 5C,D), although the amplitude of ATP-driven Ca2+ influx was also lowered at the 
higher concentration.
Discussion
In the present study we describe the generation and validation of a new GCaMP2 expressing rat strain 
with a single transgene copy per haploid genome. This transgene model was generated by a Sleeping 
Beauty transposon-based method, and the transgene expression is driven by a CAG promoter variant18. 
Utilizing the constitutive nature of this promoter, a combined genotype/phenotype screening approach 
was applied to establish a homozygous rat strain in a relatively short period of time. In accordance with 
our earlier findings with embryonic stem cells30, the highest GCaMP2 expression was found in the car-
diac tissues, especially in the atria, while appreciable transgene expression was found in the kidney and 
in the liver. Anatomical analyses found no differences in the heart size and weight between WT and TG 
animals, while slight left ventricular wall thickening was observed at the apex of the heart in transgenic 
rats. However, this did not cause any alterations in the heart function and other circulatory parameters, 
since physiological parameters of the CAG-GCaMP2 expressing rats were similar to the WT rats.
As opposed to the traditional detection methods of filling up the cells with a calcium-sensitive, often 
toxic fluorescent dyes, the genetically encoded and stably expressed calcium indicators have a clear 
advantage of providing a non-invasive platform for calcium measurements. Although new generation 
calcium sensors (e.g. GCaMP3–8) are already available31–34, most of them have higher rates of induced 
cytomorbidity which limits their applications35. In addition, they were developed to follow action poten-
tials of neurons more reliably, while GCaMP2 offers an effective system of Ca2+ signal measurements 
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Figure 4. CAG-GCaMP2 expressing cardiomyocyte cultures allow detection of ligand-induced calcium 
signals and drug-induced alteration of physiologically relevant ligand-induced calcium signals. (A) The 
effects of adrenalin, ATP, ionomycin and EGTA administration are shown on the kinetics of calcium signals 
in atrial (left panel) and in ventricular (right panel) cardiomyocyte cultures. (B) Ligand-induced calcium 
signals in wild type (WT) primary cardiac cultures loaded with the calcium-sensitive Fluo-4 AM dye.  
(C) The effects of 6.0 μ M terfenadine (left panel) or 10.0 μ M terodiline (right panel) followed by adrenalin, 
ATP, ionomycin and EGTA administration are shown on the kinetics of calcium signals in ventricular 
cell cultures. (D) The effects of 37.5 μ M mefloquine, as well as adrenalin, ATP, ionomycin and EGTA 
administration are shown on the kinetics of calcium signals in atrial (left panel) and in ventricular (right 
panel) cell cultures. For each measurement, a total number of at least 25 cells was examined; light gray lines 
represent S.E.M. values.
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in all other tissues with potentially less toxicity and side effects. The physiological relevance of the cal-
cium sensor expressing rat model was verified by the characterization of ligand-induced Ca2+ signals 
both ex vivo and in vitro. In acute ventricular slices, when spontaneous contractions were observed, the 
GCaMP2 fluorescence intensity increased parallel with the contractions. Experiments in primary cell 
cultures isolated from TG rats were performed using both atrial and ventricular cells. As documented in 
Supplemental 5, these cultured cells were mainly troponin T (cTnT) positive cardiomyocytes, and also 
showed high expression of the calcium sensor protein GCaMP2.
In this report we have examined the effect of an antimalarial agent, mefloquine, on the calcium signal 
responses in isolated cardiomyocytes. Mefloquine, a widely used agent to prevent and treat Plasmodium 
falciparum malaria, has a suspected cardiotoxicity. Mefloquine alone did not cause significant alterations 
in a healthy heart muscle36, while this compound induced changes in the heart calcium levels through 
the modulation of the L-type Ca2+ current19. In addition, pre-treatment with mefloquine potentiated the 
effects of halofantrine on the prolongation of QT intervals in anaesthetized rabbits37.
These studies raised warnings against the use of mefloquine in the case of cardiac problems. Our 
present experiments reported here indicate that in the rat cardiomyocyte model a long (24 hours) 
pre-treatment with low (near therapeutic) concentrations of mefloquine did not increase the basal cal-
cium level, but considerably decreased the calcium signals induced by adrenaline or ATP, especially in 
the atrial cells (Supplemental Figure 7A and B). Higher mefloquine concentrations induced a significant 
increase in intracellular calcium levels (Fig. 4D). Moreover, mefloquine treatment also altered the prop-
erties of Ca2+ transients both in atrial and in ventricular cells (Supplemental Figure 7A and B). These 
findings raise the possibility for a direct effect of mefloquine on cardiomyocyte calcium homeostasis. In 
addition, two drugs, terodiline and terfenadine withdrawn from the market due to QT interval prolong-
ing effect, were used to validate the CAG-GCaMP2 rat system as a potent tool for predicting cardiotoxic 
side effects. Both terodiline38 and terfenadine inhibits the rapid component of the delayed-rectifier K+ 
Figure 5. Modeling hypoxia/reoxygenation in CAG-GCaMP2 expressing ventricular cultures allows 
detection of the protecting effect of KB-R7943. (A) Control measurement in ventricular cultures without 
CoCl2 pre-treatment, showing no changes in fluorescence by medium change (MC). (B) In CoCl2-pretreated 
ventricular cultures, reoxygenation through medium change (MC) causes a significant calcium increase in 
hypoxic ventricular cells. (C) In CoCl2-pretreated ventricular cultures, administration of 0.5 μ M KB-R7943 
(ncx) reduced the calcium influx caused by reoxygenation. (D) In CoCl2-pretreated ventricular cultures, 
administration of 1 μ M KB-R7943 (NCX) eliminates the calcium influx caused by reoxygenation.
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current, therefore the increase in calcium influx detected may be a consequence of the reduction of 
active K+ channels, normally compensating calcium influx with K+ efflux in ventricular cardiomyocytes.
Our results, obtained in an in vitro hypoxia-reoxygenation model, were in agreement with previous 
studies showing that cellular Ca2+ levels increase at the time of reoxygenation (Fig.  5B)22,29, and this 
elevation can be eliminated by the NCX inhibitor KB-R7943 (Fig. 5D)23. Moreover, we found a reduced 
calcium signal induced by ATP after the addition of 1 μ M KB-R7943, showing the potential role of NCX 
in the calcium signaling of ventricular cells.
This study is the first publication dealing with the generation of a TG rat strain, stably expressing 
a calcium sensor fluorescent protein. While mouse models expressing genetically engineered calcium 
indicators have already been described14,39 the present rat model with calcium sensor expression may 
significantly improve the experimental background examining these phenomena in a widely used system 
for pharmacological and toxicological studies. The transgenic rats expressing a calcium-sensitive protein 
combined with recently developed, genetically engineered disease-specific rat strains (see SAGE, KO 
Rat Consortium, http://www.sageresearchlabs.com/research-models), could provide a valuable system for 
further elucidation of the mechanisms and potential treatments of heart diseases.
Methods
All animal protocols were approved by the Hungarian Animal Health and Animal Welfare Directorate 
according to the European Union’s most recent directives. All surgical procedures were performed 
according to the Committee on the Care and Use of Laboratory Animals of the Council on Animal Care 
at the National Institute of Oncology in Budapest, Hungary (22.1/722/3/2010).
Rat transgenesis. To establish a rat strain with a single transgene copy per haploid genome (two 
copies per animal), a combined genotype and phenotype screening procedure was applied (see Results). 
Transgenic rats were derived by microinjection of zygotes from superovulated donor females of an outbred 
Sprague-Dawley strain, and transgenic embryos were implanted into pseudopregnant Wistar female rat 
recipients (experiment license number in Hungary: PEI/001/2197-2/2013). Circular transposon plasmid 
vector15 was applied together with the SB100X transposase mRNA. The latter translation competent mRNA 
was prepared by in vitro transcription using the mMessage mMachine® T7 kit (Life Technologies). For 
genotyping, genomic DNA (gDNA) was extracted from rat tails as described earlier17, and the following 
PCR primers were used to detect the transposon: 5′ - AATTCCCTGTCTTAGGTCAGTTAGGA and 5′ - 
TTCAGGTTCAGGGGGAGGTGTGGG. As a rat gDNA control, primers 5′ - AAGATTGAATGTCT 
GTAAGTTCGAG and 5′ - TGTAATTGGTTTGGGGTTAT were used to amplify a sequence from intron 
1 of the RN-LOC500546 gene. SB transposon copy numbers were determined as described earlier24.
Organ processing. Animals were sacrificed by overdosing a 4-component anesthetic mixture (20 mg/
kg zolazepam, 12.5 mg/kg xylazine, 3 mg/kg butorphanol, 20 mg/kg tiletamine). The organs were removed, 
washed twice in PBS and were either archived for later use by snap freezing with Isopentane or fluores-
cent images were made by placing the organs into an in vivo imaging system (LT-9MACIMSYSPLUSC, 
Lightools Research). For experiments with ventricular slices the left ventricle was cut into 300 μ m thin 
section with a McIlwain tissue chopper (Mickle Laboratory Engineering Comp.).
Structural and functional characterization of cardiac muscle in transgenic and wild type ani-
mals. Fractional shortening, basal and apical thickness of the left ventricle (LV) and oxygen saturation 
were measured in both transgenic and wild type rats. The end-diastolic and end-systolic dimensions 
(EDD and ESD) of the LV were measured in M-mode by a GE LOGIQ 5 Pro ultrasound system (General 
Electric Healthcare) under 4% isoflurane anaesthesia, which was introduced directly without previous 
prenarcotic pretreatment, and fractional shortening (FS) was calculated using the following equation:
− × %EDD ESD
EDD
100
All ultrasound examinations were performed in a 5 minutes interval after anaesthesia to avoid pos-
sible pathological alterations due to anesthetic inhalation, and O2 saturation was monitored in the hind 
paw with a pulse oximeter (Pulse-BLT M700 Vet). After echocardiography the animals were euthanized 
with a single intracardial injection of barbiturate (Euthasol® 40% inj. A.U.V., Produlab Pharma b.v.), the 
heart was removed, and the basal (aprox. 3 mm from the aortic valve) and apical (3 mm from apex of 
the heart) LV wall thickness was measured by a caliper at least twice. The hearts were fixed in formalin, 
embedded in paraffin and haematoxylin-eosin stained for micro-structural analysis.
Real-time PCR analysis. Frozen rat samples were pulverized under liquid nitrogen and were 
homogenized in TRIzol™ Reagent (Life Technologies). Total RNA was isolated from tissue samples 
and RNA degradation was monitored by gel electrophoresis. cDNA samples were prepared from 1 μ g 
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total RNA using the Promega Reverse Transcription System Kit. The Pre-Developed TaqMan® assay 
for beta-2-microglobulin (B2M) (Life Technologies) was used as endogenous control in real-time qPCR 
experiments; for quantifying EFGP mRNA, specific TaqMan® assay was designed for the cDNA18. Real 
time PCR analyses were carried out using the StepOneTM Real-Time PCR System (Life Technologies); 
mRNA fold changes were determined using the 2−ΔΔCt method. Relative mRNA levels were presented as 
mean values ± S.E.M. of 3 independent experiments.
Generation of primary cell cultures from cardiac atria and ventricles. Primary cell cultures 
were established from the atria or the ventricles of 10–30 days old male TG and wild type rats. Briefly, 
the left and right atria were separated from the ventricles and were cut into ~1 mm3 pieces, similarly 
to the walls of the right and left ventricles. The pieces of the atria or the ventricles were transferred to 
a 50 ml conical tube containing 20 ml enzyme mixture of 200 U/ml type IV collagenase and 0.6 U/ml 
dispase (Life Technologies), vortexed for 1 minute then digested for 15 minutes at 37 °C. After 15 min-
utes the larger pieces were settled, the supernatant was transferred to a sterile conical tube, centrifuged 
at 300 × g for 5 minutes and the pellet was dissolved in pure fetal bovine serum (FBS). The remaining 
tissue pieces were re-digested with fresh enzyme mix. This procedure was repeated until no macro-
scopic pieces were observed. The cell suspension was filtered through a 70 micron nylon filter insert 
(BD Biosciences), centrifuged for 5 minutes at 300 × g, the supernatant was removed and the pellet was 
dissolved in complete DMEM (2% penicillin/streptomycin + 1% glutamine + 10% FBS, 25 mM HEPES). 
Cells in 300  μ L of complete DMEM were plated onto 8-well Nunc Lab-Tek II Chambered Cover glass 
(Nalgen Nunc International) covered with 0.1% gelatin. After 90 minutes the supernatant from all cham-
bers were transferred to a clean, gelatin coated chamber to enrich cardiomyocytes and decrease the 
number of fibroblasts. For experiments only secondary chambers were used and culture media were 
changed on every second day.
Immunohistochemistry. Snap-frozen tissues were cut with a cryostat into 5 μ m thin sections. The 
tissue slices were transferred onto microscope slides and were incubated with 10 mM EGTA for 5 minutes 
before fixation with methanol. Tissue sections were then washed in PBS, blocked with 2% bovine serum 
in PBS (1 hr) and incubated with a rabbit polyclonal antibody (1:500) targeting GFP (Abcam, ab290) and 
with a mouse monoclonal antibody (1:100) against cardiac Troponin T (Abcam, ab8295) in 0.5% bovine 
serum in PBS overnight at 4 °C. After a 90 minutes of PBS wash, tissue slices were incubated (1 hr) with 
Alexa Fluor 488 or Alexa Fluor 568-conjugated secondary antibody against rabbit IgG and with Alexa 
Fluor 568-conjugated secondary antibody against mouse IgG (all by 1:200; Life Technologies), washed in 
PBS and the nuclei were stained with Hoechst 33342 dye. Stained sections were mounted with ProLong 
Gold (Life Technologies). Wild type tissues were used as negative controls. Immunohistochemistry 
images were examined by an Olympus FV500-IX confocal laser scanning microscope.
Immunocytochemistry. Seven day old cultures of primary cells isolated from rat atrium or ventri-
cle were incubated with 10 mM EGTA for 5 minutes before methanol fixation and washed with PBS. 
Blocking and immunostaining were performed as described above, nuclei were stained with DAPI. For 
staining of the Na+/Ca2+ exchanger (NCX) the R3F1 antibody was used, kindly provided by Michela 
Ottolia from the Cedars-Sinai Heart Institute. Isotype and secondary antibody controls were used, and 
image detection was performed as described above.
Flow cytometry measurements (FACS). Leukocytes were obtained through red blood cell lysis, 
while primary ventricular cells were obtained as described earlier. The isolation of primary rat hepato-
cytes were performed by a three-step collagenase perfusion method40. Renal cells were isolated from the 
cortex after decapsulation and separation from the renal medulla, followed by enzymatic digestion steps 
as described previously27. Measurements were carried out in HBSS (Life Technologies). In the case of 
blood samples DRAQ5 was used to identify cells with nuclei (leukocytes) and 10 μ M Ionomycin was used 
to confirm GCaMP2 expression by testing its functionality. For primary ventricular, renal cortical cells, 
and hepatocytes 5 μ M Ionomycin was used to confirm GCaMP2 functionality. Forward scattered light 
(FSC channel), GCaMP2 expression (FL1 channel) and DRAQ5 staining (FL4 channel) were detected by 
a BD FACSCalibur flow cytometer.
Calcium signal measurements. GCaMP2 expressing primary cardiomyocytes were seeded onto 
eight-well Nunc Lab-Tek II Chambered Coverglass (Nalge Nunc International) covered by 0.1% gela-
tine. Culture media was removed by changing the medium to HBSS. In the case of ex vivo measurements 
300 μ m thin ventricular sections were placed into HBSS containing MatTek glass-bottom dishes. Ligand 
concentrations were chosen according to literature: ATP (100 μ M), adrenalin (10 μ g/ml) or ionomycin 
(5 μ M for in vitro cultures and 10 μ M for tissue slices). For calibration, EGTA was used in 5x excess of 
calcium concentration in the medium41. Calcium signal measurements were carried out by following 
time lapse sequences of cellular fluorescence recordings, and images were analyzed with the FluoView 
Tiempo (v4.3, Olympus) software. For GCaMP2 imaging, the 488 nm laser line was used for excitation 
and emission was measured between 505 and 535 nm. In confocal images artificial coloring was used for 
better visualization. Fluo-4 imaging was carried out as described previously41.
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Induction of hypoxia-reoxygenation in primary cells. To mimic hypoxia in cultured cardio-
myocytes, 400 μ M of cobalt chloride (CoCl2) was added in 500 μ L phenol-free completed media and 
incubated in normoxia (21% O2). 24 hours later the cells were transferred to the confocal microscope 
stage and the baseline cellular calcium levels were measured. Thereafter the culture medium was rap-
idly changed to phenol-free HBSS without CoCl2, and changes in fluorescent intensities were detected 
continuously.
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